Regulating Human Embryonic Stem Cell in China - A Comparative Study on Human Embryonic Stem Cell's Patentability and Morality in US and EU (Hardcover, 1st ed. 2016)

The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal funding control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research.

General

Imprint:	Springer Verlag, Singapore
Country of origin:	Singapore
Release date:	August 2016
First published:	2016
Authors:	Li Jiang
Dimensions:	235 x 155 x 14mm (L x W x T)
Format:	Hardcover
Pages:	200
Edition:	1st ed. 2016
ISBN-13:	978-981-10-2100-8
Categories:	Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Bio-ethics Books > Law > Laws of other jurisdictions & general law > Constitutional & administrative law > Citizenship & nationality law > General
LSN:	981-10-2100-7
Barcode:	9789811021008

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!